Urea Cycle Disorders: Clinical Presentation Outside the Newborn Period
Wendy E. Smith(Maine Medical Center), Marshall Summar(Children's National), Lisa Sniderman King(University of Washington), Michael C. Smith(Vanderbilt University Medical Center), Rani H. Singh(Emory University), William J. Rhead(Children's Hospital of Wisconsin), Brendan Lee(Baylor College of Medicine), Priya S. Kishnani(Duke Medical Center)
Cited by 91
Related Papers
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
|Journal of the American Society of Nephrology|2011|856
Phenylalanine hydroxylase deficiency: diagnosis and management guideline
|Genetics in Medicine|2014|718
Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle Disorders
|New England Journal of Medicine|2007|357
Glycogen Storage Disease Type III diagnosis and management guidelines
|Genetics in Medicine|2010|305
Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
|Genetics in Medicine|2009|292